Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dietary Peanuts and Nutrition-Related Outcomes

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.

Participants needed: 64
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Ian J. Neeland, MDUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weigh...

No use or contraindication to use of a GLP-1 RA [+3]

Status: Recruiting

Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

In this study will look at how eating pistachios every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding pistachios to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating pistachios improves overall diet quality and health markers like tiredness and certain levels in blood.

Participants needed: 108
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Ian J. Neeland, MDUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weigh...

No use or contraindication to use of a GLP-1 RA [+3]